![David Reddy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Reddy
Algemeen Directeur bij MMV Medicines for Malaria Venture
Profiel
David Reddy currently works at MMV Medicines for Malaria Venture, as Chief Executive Officer & Director from 2010, International Federation of Pharmaceutical Manufacturers, as Director General from 2024, and Malaria No More UK, as Trustee from 2019.
Actieve functies van David Reddy
Bedrijven | Functie | Begin |
---|---|---|
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Algemeen Directeur | 01-01-2010 |
Malaria No More UK
![]() Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | Directeur/Bestuurslid | 01-01-2019 |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Algemeen Directeur | 01-04-2024 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 3 |
---|---|
MMV Medicines for Malaria Venture
![]() MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services MMV Medicines for Malaria Venture engages in the research, development, and discovery of antimalarial drugs. It focuses on developing medicines for case management, including patient-adapted new combinations to overcome drug resistance, to facilitate deployment of shorter treatment courses, and to protect vulnerable populations like children and pregnant women. The company was founded on November 3, 1999 and is headquartered in Geneva, Switzerland. | Commercial Services |
Malaria No More UK
![]() Malaria No More UK Advertising/Marketing ServicesCommercial Services Malaria No More UK is an organization dedicated to ending malaria. The non-profit company is based in London, UK and is part of an effort to put an end to the suffering and death caused by malaria. The British company aims to put the fight against malaria in the spotlight and ensure that they are the generation that will end it for good. The malaria death rate has fallen by 60% since 2000, saving 7.6 million lives, but progress has stalled with a child dying every minute. The company believes that with the help of everyone, they can save the 3.7 billion people at risk. The company was founded in 2009 by Peter F. Chernin, Simon Robert Fuller, and James Whiting has been the CEO of the company since 2012. | Commercial Services |
International Federation of Pharmaceutical Manufacturers
![]() International Federation of Pharmaceutical Manufacturers BiotechnologyHealth Technology The International Federation of Pharmaceutical Manufacturers and Traders is a global organization that promotes technology transfer in the pharmaceutical industry. The non-profit company is based in Geneva, Switzerland. The Swiss company believes that technology transfer helps bridge research and development gaps, increases the availability of vaccines and medicines, and stimulates investment in key industrial areas. David Reddy has been the CEO of the company since 2024. | Health Technology |